
Pfizer-Innovent $10.5B Deal & China Licensing Playbook
Examine the $10.5B Pfizer-Innovent collaboration. This analysis covers their 12-drug ADC oncology portfolio and the China cross-border licensing playbook.

Examine the $10.5B Pfizer-Innovent collaboration. This analysis covers their 12-drug ADC oncology portfolio and the China cross-border licensing playbook.

Analyze Eli Lilly's 2026 AI partnership map and co-innovation strategy. Learn how collaborations with NVIDIA, Insilico, and Chai advance drug discovery.
© 2026 IntuitionLabs. All rights reserved.